These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9247940)

  • 1. Ketoconazole resistant oral candidiasis in HIV-infected patients.
    Diz Dios P; Vázquez García E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Jul; 84(1):3-4. PubMed ID: 9247940
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.
    Cartledge JD; Midgley J; Gazzard BG
    J Antimicrob Chemother; 1997 Jul; 40(1):117-9. PubMed ID: 9249214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.
    St-Germain G; Dion C; Espinel-Ingroff A; Ratelle J; de Repentigny L
    J Antimicrob Chemother; 1995 Jul; 36(1):109-18. PubMed ID: 8537258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility and sterol biosynthesis of Candida albicans strains after long-term treatment with azoles in HIV-infected patients.
    Hundt W; Hofmann H
    Infection; 1994; 22(2):124-31. PubMed ID: 8070926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
    Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
    Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
    Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
    Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant oral candidiasis in patients with HIV infection: a systematic review and meta-analysis.
    Keyvanfar A; Najafiarab H; Talebian N; Tafti MF; Adeli G; Ghasemi Z; Tehrani S
    BMC Infect Dis; 2024 May; 24(1):546. PubMed ID: 38822256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we prevent azole resistance in fungi?
    Denning DW
    Lancet; 1995 Aug; 346(8973):454-5. PubMed ID: 7637473
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole-resistant Candida in AIDS patients. Report of two cases.
    Heinic GS; Stevens DA; Greenspan D; MacPhail LA; Dodd CL; Stringari S; Strull WM; Hollander H
    Oral Surg Oral Med Oral Pathol; 1993 Dec; 76(6):711-5. PubMed ID: 8284074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
    Cartledge JD; Midgley J; Petrou M; Shanson D; Gazzard BG
    J Antimicrob Chemother; 1997 Oct; 40(4):517-23. PubMed ID: 9372421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis.
    Silverman S; Gallo JW; McKnight ML; Mayer P; deSanz S; Tan MM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):402-7. PubMed ID: 8899777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals.
    Blignaut E; Messer S; Hollis RJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Oct; 44(2):169-74. PubMed ID: 12458124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.